OncoImmunology – Bispecific and multispecific antibodies for cancer therapy: call for papers
Do you have original research or review papers you wish to publish on bispecific and multispecific antibodies? Our partnered journal OncoImmunology invites you to submit your paper to its latest Article Collection entitled ‘Bispecific and multispecific antibodies for cancer therapy’.
Please reach out to Commissioning Editor Cassie Houtz ([email protected]) for more information and to receive a discount on the journal’s Article Processing Charge (APC).
The journal is particularly interested in papers on the following topics:
- Pre-clinical development, including target identification, bispecific antibody platforms and engineering strategies.
- Clinical development and applications of multispecific antibodies in lymphoma, myeloma and leukemia.
- Clinical development and applications of multispecific antibodies in lung, breast, hepatobiliary cancer and others.
- Emerging constructs.
- Mechanisms of resistance to multispecific antibodies and strategies to overcome them.
For further information, please view the journal Aims and Scope. The deadline for submissions is 31 January 2025.